Five Lives MED for Mild Cognitive Impairment
Five Lives MED to Improve Cognitive Function in Mild Cognitive Impairment
Recruiting
N/A
Interventional Study
Mild Cognitive Impairment
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 50 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Basic Science
- Participants needed
- 170 (estimated)
- Sponsor
- SharpTx · Industry
Who this trial is looking for
This trial is looking for adults aged 50 and older with mild cognitive impairment (MCI). Participants will use the Five Lives MED app at home for 12 weeks and complete cognitive tests and questionnaires.
Are You a Good Fit for This Trial?
You may be able to join if
- I have been diagnosed with mild cognitive impairment.
- I am 50 years old or older.
- I can give informed consent to participate.
- I can read and understand English or French.
- I have access to a compatible mobile device with internet.
You may not be able to join if
- I have been diagnosed with dementia.
- I have severe visual impairment.
- I am currently undergoing another cognitive program.
- I am participating in another study that may affect this study.
- I have a physical impairment that makes using a mobile device impossible.
- I do not have access to an informant.
- I am under guardianship.
- I am unwilling or unable to engage with the study.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this randomized controlled trial is to determine whether the digital health app Five Lives MED can improve cognitive function in people with mild cognitive impairment (MCI). The main question it aims to answer is:
Can 12 weeks of using Five Lives MED improve global cognitive function in people diagnosed with MCI?
Researchers will compare with a control group who receives a leaflet wi…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of Mild Cognitive Impairment (also known as mild cognitive disorder \[ICD-10-CM; G31.84\] or mild neurocognitive disorder (DSM-5)
* Age ≥ 50
* Participant or informant is willing and able to give informed consent for participation in the study
* Ability to read and u…
Contacts